References
- Andersen S, Eilertsen M, Donnem T, et al (2011). Diverging prognostic impacts of hypoxic markers according to NSCLC histology. Lung Cancer, 72(3): 294-302. https://doi.org/10.1016/j.lungcan.2010.10.006
- Azab B, Kedia S, Shah N, et al (2013). The value of the pretreatment albumin/globulin ratio in predicting the longterm survival in colorectal cancer. Int J Colorectal Dis, 28,1629-36. https://doi.org/10.1007/s00384-013-1748-z
- Azab BN, Bhatt VR, Vonfrolio S, et al (2013). Value of the pretreatment albumin to globulin ratio in predicting long-term mortality in breast cancer patients. Am J Surg, 206,764-70. https://doi.org/10.1016/j.amjsurg.2013.03.007
- Canna K, McArdle PA, McMillan DC, et al (2005). The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Br J Cancer, 92,651-4. https://doi.org/10.1038/sj.bjc.6602419
- Cueto Manzano AM (2001). Hypoalbuminemia in dialysis. Is it a marker for malnutrition or inflammation? Rev Invest Clin, 53,152-8.
- Dai J, Tang K, Xiao W, et al (2014). Prognostic significance of C-reactive protein in urological cancers: a systematic review and meta-analysis. Asian Pac J Cancer Prev, 15, 3369-75. https://doi.org/10.7314/APJCP.2014.15.8.3369
- Du XJ, Tang LL, Mao YP, et al (2014). The Pretreatment albumin to globulin ratio has predictive value for long-term mortality in nasopharyngeal carcinoma. PLoS ONE, 9, e94473. https://doi.org/10.1371/journal.pone.0094473
- de Geus-Oei LF, van Krieken JH, Aliredjo RP, et al (2007). Biological correlates of FDG uptake in non-small cell lung cancer. Lung Cancer, 55, 79-87. https://doi.org/10.1016/j.lungcan.2006.08.018
- Gabay C, Kushner I. (1999). Acute-phase proteins and other systemic responses to inflammation. N Engl J Med, 340, 448-54. https://doi.org/10.1056/NEJM199902113400607
- Greene FL, Page DL, Fleming ID (2002). AJCC cancer staging manual.6th ed. New York: Springer-Verlag.
- Guo YZ, Pan L, Du CJ, Ren DQ, Xie XM (2013). Association between C-reactive protein and risk of cancer: a metaanalysis of prospective cohort studies. Asian Pac J Cancer Prev, 14, 243-8. https://doi.org/10.7314/APJCP.2013.14.1.243
- Gupta D, Lis CG (2010). Pretreatment serum albumin as a predictor of cancersurvival: a systematic review of the epidemiological literature. Nutr J, 9, 69. https://doi.org/10.1186/1475-2891-9-69
- Jemal A, Siegel R, Xu J, Ward E (2010). Cancer statistics. CA Cancer J Clin, 60, 277-300. https://doi.org/10.3322/caac.20073
- Jin Y1, Zhao L, Peng F (2013). Prognostic impact of serum albumin levels on the recurrence of stage I non-small cell lung cancer. Clinics (Sao Paulo), 68, 686-93. https://doi.org/10.6061/clinics/2013(05)17
- Kaya V, Yildirim M, Demirpence O, Yildiz M, Yalcin AY (2013) Prognostic significance of basic laboratory methods in nonsmall-cell-lung cancer. Asian Pac J Cancer Prev, 14, 5473-6. https://doi.org/10.7314/APJCP.2013.14.9.5473
- Laky B, Janda M, Bauer J, et al (2007). Malnutrition among gynaecological cancer patients. Eur J Clin Nutr, 61, 642-6.
- Laursen I, Briand P, Lykkesfeldt AE (1990). Serum albumin as a modulator on growth of the human breast cancer cell line, MCF-7. Anticancer Res, 10, 343-51.
- Mantovani A, Allavena P, Sica A, Balkwill F (2008). Cancerrelated inflammation. Nature, 454, 436-44. https://doi.org/10.1038/nature07205
- McMillan DC (2009). Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care, 12, 223-6. https://doi.org/10.1097/MCO.0b013e32832a7902
- McPherson R. Specific proteins. In: McPherson RA, Pincus MR, editors (2006). Henry's clinical diagnosis and management by laboratory methods. 21st ed. New York: Saunders.
- Onate-Ocana LF, Aiello-Crocifoglio V, Gallardo-Rincon D, et al (2007). Serum albumin as a significant prognostic factor for patients with gastric carcinoma. Ann Surg Oncol, 14, 381-9. https://doi.org/10.1245/s10434-006-9093-x
- Shimada H, Nabeya Y, Okazumi S, et al (2003). Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma. J Surg Oncol, 83, 248-52. https://doi.org/10.1002/jso.10275
- Soliman NA, Keshk WA, Shoheib ZS, Ashour DS, Shamloula MM (2014). Inflammation, oxidative stress and L-fucose as indispensable participants in schistosomiasis-associated colonic dysplasia. Asian Pac J Cancer Prev, 15, 1125-31. https://doi.org/10.7314/APJCP.2014.15.3.1125
- Song XY, Zhou SJ, Xiao N, et al (2013). Research on the relationship between serum levels of inflammatory cytokines and non-small cell lung cancer. Asian Pac J Cancer Prev,14, 4765-8. https://doi.org/10.7314/APJCP.2013.14.8.4765
- Sonnenschein C, Soto AM, Michaelson CL (1996). Human serum albumin shares the properties of estrocolyone-I, the inhibitor of the proliferation of estrogen-target cells. J Steroid Biochem Mol Biol, 59, 147-54. https://doi.org/10.1016/S0960-0760(96)00112-4
- Unal D, Eroglu C, Kurtul N, Oguz A, Tasdemir A (2013). Are neutrophil/lymphocyte and platelet/lymphocyte rates in patients with non-small cell lung cancer associated with treatment response and prognosis? Asian Pac J Cancer Prev, 14, 5237-42. https://doi.org/10.7314/APJCP.2013.14.9.5237
- Yeun JY, Kaysen GA (1998). Factors influencing serum albumin in dialysis patients. Am J Kidney Dis, 32, 118-25.
- Yildirim M, Yildiz M, Duman E, Goktas S, Kaya V (2013). Prognostic importance of the nutritional status and systemic inflammatory response in non-small cell lung cancer. J BUON, 18, 728-32.
- Zheng YB, Zhao W, Liu B, et al (2013). The blood neutrophil-tolymphocyte ratio predicts survival in patients with advanced hepatocellular carcinoma receiving sorafenib. Asian Pac J Cancer Prev, 14, 5527-31. https://doi.org/10.7314/APJCP.2013.14.9.5527
Cited by
- The Gamma Gap and All-Cause Mortality vol.10, pp.12, 2015, https://doi.org/10.1371/journal.pone.0143494
- Prognostic Significance of Preoperative Albumin-Globulin Ratio in Patients with Upper Tract Urothelial Carcinoma vol.10, pp.12, 2015, https://doi.org/10.1371/journal.pone.0144961
- The pretreatment albumin to globulin ratio predicts chemotherapeutic outcomes in patients with unresectable metastatic colorectal cancer vol.15, pp.1, 2015, https://doi.org/10.1186/s12885-015-1375-x
- Low pretreatment serum globulin may predict favorable prognosis for gastric cancer patients vol.37, pp.3, 2016, https://doi.org/10.1007/s13277-015-3778-3
- Pretreatment values of bilirubin and albumin are not prognostic predictors in patients with advanced pancreatic cancer pp.20457634, 2018, https://doi.org/10.1002/cam4.1848
- Preoperative albumin-to-globulin ratio predicts survival in patients with non-small-cell lung cancer after surgery pp.00219541, 2018, https://doi.org/10.1002/jcp.26766